Publications
50
Citations
1,456
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1998
Erik Parker's research spans brain cancer biology and the study of microbial communities (the microbiome) in health and disease. Earlier work examined how a cell-surface receptor called GPR133 contributes to the growth of glioblastoma, an aggressive brain tumor, while more recent work explores how gut and other microbiomes relate to metabolism, cognition, and aging in animal models. The topics reflect a shift from tumor cell biology toward microbiome-focused studies.
Publication activity was minimal for several years and then increased around 2023–2024, indicating recent growth in output.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Investigating the effect of dental abnormalities on equine fecal microbiome
Journal of Equine Veterinary Science · 2025
- Microbiome-driven alterations in metabolic pathways and impaired cognition in aged female TgF344-AD rats
Aging Brain · 2024
- GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth
Oncogenesis · 2016
- 13. The Analysis of Atmospheric Sensory Data Obtained from a Weather Balloon System
Scholarly Commons (Embry–Riddle Aeronautical University) · 2016
- STMC-25. GPR133 PROMOTES HYPOXIA-DRIVEN TUMOR PROGRESSION IN GLIOBLASTOMA
Neuro-Oncology · 2016
- Oncogenesis×1
- Frontiers in Allergy×1
- Social Science Quarterly×1
- Aging Brain×1
- American Journal of Clinical Nutrition×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile